Protein kinase c α but not PKCζ suppresses intestinal tumor formation in ApcMin/+ mice

被引:91
作者
Oster, Henrik
Leitges, Michael
机构
[1] Hannover Med Sch, Dept Internal Med Nephrol, Lab Singal Transduct, Max Planck Inst Expt Endocrinol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany
关键词
D O I
10.1158/0008-5472.CAN-06-0268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Members of the protein kinase C (PKC) family of serine/threonine kinases play key regulatory roles in numerous cellular processes, including differentiation and proliferation. Of the 11 mammalian PKC isoforms known, several have been implicated in tumor development and progression. However, in most cases, isotype specificity is poorly defined, and even contrary functions for a single PKC have been reported mostly because appropriate molecular and genetic tools were missing to specifically assess the contribution of single PKC isoforms in vivo. In this report, we therefore used PKC genetic targeting to study the role of PKC alpha and PKC zeta in colorectal cancer. Both isoforms were found to be strongly down-regulated in intestinal tumors of Apc(Min/+) mice. A deletion of PKC zeta did not affect tumorigenesis in this animal model. In contrast, PKC alpha-deficient Apc(Min/+) mice developed more aggressive tumors and died significantly earlier than their PKC alpha-proficient litter-mates. Even without an additional Apc mutation, PKC alpha knockout mice showed an elevated tendency to develop spontaneous intestinal tumors. Transcriptional profiling revealed a role for this kinase in regulating epidermal growth factor receptor (EGFR) signaling and proposed a synergistic mechanism for EGFR/activator protein and WNT/APC pathways in mediating intestinal tumor development.
引用
收藏
页码:6955 / 6963
页数:9
相关论文
共 67 条
[1]  
AHN NG, 1990, J BIOL CHEM, V265, P11487
[2]   Pathology of mouse models of intestinal cancer: Consensus report and recommendations [J].
Boivin, GP ;
Washington, K ;
Yang, K ;
Ward, JM ;
Pretlow, TP ;
Russell, R ;
Besselsen, DG ;
Godfrey, VL ;
Doetschman, T ;
Dove, WF ;
Pitot, HC ;
Halberg, RB ;
Itzkowitz, SH ;
Groden, J ;
Coffey, RJ .
GASTROENTEROLOGY, 2003, 124 (03) :762-777
[3]  
CASTAGNA M, 1982, J BIOL CHEM, V257, P7847
[4]   1,25-dihydroxyvitamin D3 stimulates activator protein-1-dependent CaCo-2 cell differentiation [J].
Chen, AP ;
Davis, BH ;
Bissonnette, M ;
Scaglione-Sewell, B ;
Brasitus, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35505-35513
[5]  
Chida K, 2003, CANCER RES, V63, P2404
[6]   How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men [J].
Corpet, DE ;
Pierre, F .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (13) :1911-1922
[7]   LOSS OF PROTEIN-KINASE-C DELTA-ISOZYME IMMUNOREACTIVITY IN HUMAN ADENOCARCINOMAS [J].
CRAVEN, PA ;
DERUBERTIS, FR .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (03) :481-489
[8]   ALTERATIONS IN PROTEIN-KINASE-C SYSTEM OF COLONIC EPITHELIUM DURING FASTING REFEEDING - EVIDENCE FOR PROTEIN-KINASE-C INDEPENDENT PATHWAY OF ENHANCED PROLIFERATIVE ACTIVITY [J].
CRAVEN, PA ;
DERUBERTIS, FR .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (08) :1162-1169
[9]  
Cripps MC, 2002, CLIN CANCER RES, V8, P2188
[10]   Non-invasive detection of fecal protein kinase CβΠ and ζ messenger RNA:: putative biomarkers for colon cancer [J].
Davidson, LA ;
Aymond, CM ;
Jiang, YH ;
Turner, ND ;
Lupton, JR ;
Chapkin, RS .
CARCINOGENESIS, 1998, 19 (02) :253-257